Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$42,279,160
+$1,722,173 QoQ
Shares Held
150,997
-0.7% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#75
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,243,802,437 across 31 Diagnostics & Research names. LH ranks #11 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
593,946 | $297,780,766 | |
| 2 | DHR |
Danaher Corp /De/
|
995,923 | $189,703,413 | |
| 3 | ILMN |
Illumina, Inc.
|
560,716 | $98,590,694 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
169,208 | $89,077,859 | |
| 5 | A |
Agilent Technologies, Inc.
|
500,807 | $66,522,193 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
332,138 | $64,175,704 | |
| 7 | WAT |
Waters Corp /De/
|
168,771 | $63,295,875 | |
| 8 | DGX |
Quest Diagnostics Inc
|
267,727 | $56,744,737 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,279,160 | 150,997 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $40,556,987 | 152,007 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $38,293,068 | 152,635 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $44,260,059 | 154,184 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $40,633,660 | 154,789 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $36,160,348 | 155,368 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $32,777,854 | 142,935 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $32,492,651 | 145,394 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $29,992,082 | 147,374 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||